Cited by 298Estrogen and related hormone effectsProstate Cancer Treatment and ResearchBreast Cancer Treatment Studies

The DOI matches its Crossref record; 148 of the 152 references it cites were found in a registry or an index.

Minireview: The Androgen Receptor in Breast Tissues: Growth Inhibitor, Tumor Suppressor, Oncogene?

Open access

Hickey, T. E., Robinson, J. L. L., Carroll, J. S., Tilley, W. D.·2012·Molecular Endocrinology

DOI 10.1210/me.2012-1107PMC PMC3404296

Open this paper in CoChat — free account Open PDF

Abstract

Androgen receptor (AR) signaling exerts an antiestrogenic, growth-inhibitory influence in normal breast tissue, and this role may be sustained in estrogen receptor α (ERα)-positive luminal breast cancers. Conversely, AR signaling may promote growth of a subset of ERα-negative, AR-positive breast cancers with a molecular apocrine phenotype. Understanding the molecular mechanisms whereby androgens can elicit distinct gene expression programs and opposing proliferative responses in these two breast cancer phenotypes is critical to the development of new therapeutic strategies to target the AR in breast cancer.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1210/me.2012-1107

Cites

148 of 148 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Molecular portraits of human breast tumours
Perou, C., Sørlie, T., Eisen, M., van de Rijn, M., Jeffrey, S., Rees, C. A., Pollack, J., Ross, D., Johnsen, H., Akslen, L., et al. (2000) · Nature · doi:10.1038/35021093 · Cited by 16,551
Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications
Sørlie, T., Perou, C. M., Tibshirani, R. J., Aas, T., Geisler, S. B., Johnsen, H., Hastie, T. J., Eisen, M. B., van de Rijn, M., Jeffrey, S. S., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.191367098 · Cited by 11,506
Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies
Lehmann, B. D., Bauer, J. A., Chen, X., Sanders, M. E., Chakravarthy, A. B., Shyr, Y., & Pietenpol, J. A. (2011) · Journal of Clinical Investigation · doi:10.1172/jci45014 · Cited by 5,592
Repeated observation of breast tumor subtypes in independent gene expression data sets
Sørlie, T., Tibshirani, R. J., Parker, J. S., Hastie, T. J., Marron, J. S., Nobel, A. B., Deng, S., Johnsen, H., Pesich, R., Geisler, S. B., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0932692100 · Cited by 5,508
A collection of breast cancer cell lines for the study of functionally distinct cancer subtypes
Neve, R. M., Chin, K., Fridlyand, J., Yeh, J., Baehner, F. L., Fevr, T., Clark, L., Bayani, N., Coppé, J., Tong, F. K., et al. (2006) · Cancer Cell · doi:10.1016/j.ccr.2006.10.008 · Cited by 3,224
Differential oestrogen receptor binding is associated with clinical outcome in breast cancer
Ross-Innes, C. S., Stark, R., Teschendorff, A. E., Holmes, K. A., Ali, H. R., Dunning, M., Brown, G. D., Gojiš, O., Ellis, I. O., Green, A. R., et al. (2012) · Nature · doi:10.1038/nature10730 · Cited by 2,182
Estrogen Carcinogenesis in Breast Cancer
Yager, J. D., & Davidson, N. E. (2006) · New England Journal of Medicine · doi:10.1056/nejmra050776 · Cited by 1,890
Breast Cancer Molecular Subtypes Respond Differently to Preoperative Chemotherapy
Rouzier, R., Perou, C. M., Symmans, W. F., Ibrahim, N. K., Cristofanilli, M., Anderson, K., Hess, K. R., Stec, J. J., Ayers, M., Wagner, P., et al. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-2421 · Cited by 1,889
Differential Oestrogen Receptor Binding is Associated with Clinical Outcome in Breast Cancer
Stark, R. (2012) · Lecture notes in computer science · doi:10.1007/978-3-642-29627-7_30 · Cited by 1,403
Sequence and Expression of Human Estrogen Receptor Complementary DNA
Greene, G. L., Gilna, P., Waterfield, M. D., BAKER, A. J., Hort, Y., & Shine, J. (1986) · Science · doi:10.1126/science.3753802 · Cited by 1,311

Show all 152 references

Sorted by citations

Items 201–298 of 298

Distribution and characteristics of androgen receptor (AR) in breast cancer among women in Addis Ababa, Ethiopia: A cross sectional study
Gebregzabher, E. H., Seifu, D., Tigneh, W., Bokretsion, Y., Bekele, A., Abebe, M., Sollie, T., Karlsson, C., & Karlsson, M. G. (2020) · PLoS ONE · doi:10.1371/journal.pone.0232519 · Cited by 5
Diane-35 and metformin therapy in rats with endometrial lesions induced by dihydrotestosterone exposure
Liu, Y., Xu, R., Zhou, Y., Wang, Y., Zhang, F., Tong, X., Cui, P., Ma, T., Sun, J. L., Feng, Y., et al. (2023) · Annals of Translational Medicine · doi:10.21037/atm-21-2441 · Cited by 5
Impact of steroid hormone levels on estradiol‐mediated regulation of cytochrome P450 2B6 compared to 1B1 in breast cancer cells
Hoffmann, M., Müller, J. P., Maurer, J., Folliot, A., Yamoune, S., & Stingl, J. (2024) · Basic & Clinical Pharmacology & Toxicology · doi:10.1111/bcpt.14069 · Cited by 5
GATA-3 expression is not associated with complete pathological response in triple negative breast cancer patients treated with neoadjuvant chemotherapy
Wasserman, J. K., Williams, P. A., Islam, S., & Robertson, S. J. (2016) · Pathology - Research and Practice · doi:10.1016/j.prp.2016.03.004 · Cited by 5
New Entrants into Clinical Trials for Targeted Therapy of Breast Cancer: An Insight
Verma, P., Mittal, P., Singh, A. K., & Singh, I. K. (2019) · Anti-Cancer Agents in Medicinal Chemistry · doi:10.2174/1871520619666191018172926 · Cited by 5
Classification of breast tumours into molecular apocrine, luminal and basal groups based on an explicit biological modelPreprint
Iggo, R. D. (2018) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/270975 · Cited by 5
Paving the path ForwARd: Advances and challenges in androgen receptor targeting in breast cancer
Sridhar, N., Iwase, T., Xie, X., Lee, J., Damodaran, S., & Ueno, N. T. (2025) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2025.102958 · Cited by 4
Breast Cancer Risk with Progestin Subdermal Implants: A Challenge in Patients Counseling
Mohammed, G., Mousa, N. A., Talaat, I. M., Ibrahim, H., & Saber-Ayad, M. M. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.781066 · Cited by 4
Beyond Hormone Receptors: liquid biopsy tools to unveil new clinical meanings and empower therapeutic decision-making in Luminal-like metastatic breast cancer
Pastò, B., Vida, R., Dri, A., Foffano, L., Rossa, S. D., Gerratana, L., & Puglisi, F. (2024) · The Breast · doi:10.1016/j.breast.2024.103859 · Cited by 4
Predictive and Prognostic Values of Glycoprotein 96, Androgen Receptors, and Extranodal Extension in Sentinel Lymph Node-Positive Breast Cancer: An Immunohistochemical Retrospective Study
Gembić, T. K., Grebić, D., Gulić, T., Golemac, M., & Avirović, M. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13247665 · Cited by 4
Surrogate molecular classification of LAR breast cancer in routine workflow
Rangel, N., Serrao, L., Capella, G., Orlando, G., Ragno, F., Rondón‐Lagos, M., Metović, J., Cassoni, P., & Castellano, I. (2025) · Endocrine Related Cancer · doi:10.1530/erc-24-0316 · Cited by 4
Higher Expressions of SHH and AR Are Associated with a Positive Receptor Status and Have Impact on Survival in a Cohort of Croatian Breast Cancer Patients
Budimir, I., Tomasović‐Lončarić, Č., Kralik, K., Čonkaš, J., Eljuga, D., Žic, R., Gorjanc, B., Tucaković, H., Caktaš, D., Jaman, J., et al. (2022) · Life · doi:10.3390/life12101559 · Cited by 4
Androgens Modulate Bcl-2 Agonist of Cell Death (BAD) Expression and Function in Breast Cancer Cells
Morelli, C., Chiodo, C., Nocito, M. C., Cormace, A., Catalano, S., Sisci, D., Sirianni, R., Casaburi, I., Andò, S., & Lanzino, M. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241713464 · Cited by 5
Androgen receptor expression in triple negative breast cancer and its relationship to prognostic factors
Kneubil, M. C., Godoy, A. E. G., Coelho, G. P., Grochot, R. M., Rombaldi, R. L., Pasqualotto, F. F., Raimann, B. W., Madi, J. M., Reiriz, A. B., Alessi, M., et al. (2017) · Revista Brasileira de Mastologia · doi:10.5327/z2594539420170000205 · Cited by 4
Biological rationale for a patient-specific approach in the treatment of breast cancer. Clinical value of novel biomarkers of breast cancer
Палтуев, Р. М. (2019) · Tumors of female reproductive system · doi:10.17650/1994-4098-2019-15-2-10-29 · Cited by 4
Effects of doxorubicin associated with amniotic membrane stem cells in the treatment of canine inflammatory breast carcinoma (IPC-366) cells
Borghesi, J., Cáceres, S., Mario, L. C., Alonso‐Diez, Á., Rabêlo, A. C. S., Illera, M. J., Silván, G., Miglino, M. A., Favaron, P. O., Carreira, A. C. O., et al. (2020) · BMC Veterinary Research · doi:10.1186/s12917-020-02576-0 · Cited by 4
Unveiling the Future of Oncology and Precision Medicine through Data Science
Zaravinos, A. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25115797 · Cited by 4
MicroRNA signature of stromal-epithelial interactions in prostate and breast cancers
Choudhury, A. R., Nagesh, A. M., Gupta, S., Chaturvedi, P. K., Kumar, N., Sandeep, K., & Pandey, D. (2024) · Experimental Cell Research · doi:10.1016/j.yexcr.2024.114171 · Cited by 3
Are androgen receptor agonists a treatment option in bladder cancer?
Ieso, M. L. D., Aldoghachi, A. F., Tilley, W. D., & Dwyer, A. R. (2024) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2024.106623 · Cited by 3
AR Expression Correlates with Distinctive Clinicopathological and Genomic Features in Breast Cancer Regardless of ESR1 Expression Status
Long, M., You, C., Song, Q., Hu, L. X. J., Guo, Z., Yao, Q., Hou, W., Sun, W., Liang, B., Zhou, X., et al. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms231911468 · Cited by 3
Androgênios e mama
Florencio‐Silva, R., Sasso, G. R. D. S., Girão, J. H. R. C., Baracat, M. C. P., & Simões, R. S. (2017) · Reprodução & Climatério · doi:10.1016/j.recli.2017.02.001 · Cited by 4
Medical ovariectomy in menopausal breast cancer patients with high testosterone levels: a further step toward tailored therapy
Secreto, G., Muti, P. C., Sant, M., Meneghini, E., & Krogh, V. (2017) · Endocrine Related Cancer · doi:10.1530/erc-17-0251 · Cited by 3
Towards a Treatment for Gulf War Illness: A Consensus Docking Approach
Jaundoo, R., Bohmann, J. A., Gutierrez, G. E., Klimas, N. G., Broderick, G., & Craddock, T. J. A. (2020) · Military Medicine · doi:10.1093/milmed/usz299 · Cited by 2
Malignant adnexal tumor of the skin on breast: A case report of apocrine carcinoma
Adiputra, P. A. T., Sudarsa, I. W., Irawan, H., & Saputra, H. (2023) · International Journal of Surgery Case Reports · doi:10.1016/j.ijscr.2023.108383 · Cited by 2
Androgen Signaling in Other Body Systems
Smith, L. B., & McEwan, I. J. (2013) · SpringerBriefs in reproductive biology · doi:10.1007/978-1-4614-8978-8_5 · Cited by 2
Expression, purification and crystallization of the ancestral androgen receptor–DHT complex
Colucci, J. K., & Ortlund, E. A. (2013) · Acta Crystallographica Section F Structural Biology and Crystallization Communications · doi:10.1107/s1744309113018745 · Cited by 2
Histological grade (HG) in invasive ductal carcinomas of the breast of less than 1 cm: clinical and biological associations during progression from HG1 to HG3.
Ruibal, Á., Aguiar, P., Rio, M. C. D., Arias, J. I., Menéndez‐Rodríguez, P., Gudé, F., & Herranz, M. (2015) · PubMed · Cited by 2
Sequential Colocalization of ERa, PR, and AR Hormone Receptors Using Confocal Microscopy Enables New Insights into Normal Breast and Prostate Tissue and Cancers
Chenlo, M., Aliyev, E., Rodrigues, J. S., Vieiro‐Balo, P., Freire, M. N. B., Cameselle‐Teijeiro, J., & Álvarez, C. V. (2020) · Cancers · doi:10.3390/cancers12123591 · Cited by 2
Single cell RNA-sequencing reveals that testosterone reduces estrogen signaling in the healthy human mammary gland
Phong, K. T., Song, S., Kim, E. A., Conrad, D. N., & Gartner, Z. J. (2026) · Journal of Mammary Gland Biology and Neoplasia · doi:10.1007/s10911-026-09605-y · Cited by 1
Androgen Receptor (AR) Expression is Associated with an Immune-Cold Phenotype and Reduced Response to Immune Checkpoint Inhibitors in ER-Positive/HER2-Negative Breast Cancer
Arima, J., Chida, K., Wu, R., Shima, T., Kuramoto, T., Hamamoto, H., Taniguchi, K., Shah, Z., Hakamada, K., Ishikawa, T., et al. (2026) · Annals of Surgical Oncology · doi:10.1245/s10434-026-20685-2 · Cited by 1
Can the androgen receptor blocking become the basis of a new method of treatment of triple negative breast cancer?
Ziltsova, E. K., IVANOVA, O. A., Криворотько, П. В., Иванов, В. Г., Цырлина, Е. В., Dashyan, G. A., Табагуа, Т. Т., Николаев, К. С., Гиголаева, Л. П., & Семиглазов, В. Ф. (2017) · Malignant tumours · doi:10.18027/2224-5057-2017-1-18-25 · Cited by 1
Apocrine carcinoma of the breast: Review
Yang, C., Wang, Z. I., & Yen, Y. (2022) · Forum of Clinical Oncology · doi:10.2478/fco-2023-0007 · Cited by 1
Portable NMR for the investigation of models of mammographic density ex vivo: Androgens antagonise the promotional effect of oestrogen
Huang, X., Reye, G., Momot, K. I., Blick, T., Lloyd, T., Tilley, W. D., Hickey, T. E., Snell, C. E., Thompson, E. W., & Hugo, H. J. (2023) · Biomedical Spectroscopy and Imaging · doi:10.3233/bsi-230000 · Cited by 1
A Closer Look at the Androgen Receptor (AR)- positive and AR-negative Metastatic Triple-Negative Breast Cancer: Can We Apply Novel Targeted Therapeutics?
Rygiel, K. (2023) · BENTHAM SCIENCE PUBLISHERS eBooks · doi:10.2174/9789815196023123010004 · Cited by 1
Androgen Receptor and Breast Cancer
Sismondi, P., D’Alonzo, M., Bounous, V. E., Quintili, F., Ferrero, A., Mariani, L. L., & Biglia, N. (2014) · ISGE series · doi:10.1007/978-3-319-09662-9_19 · Cited by 1
Novel Imaging Based Biomarkers in Breast Cancer
Edmonds, C. E., & Mankoff, D. A. (2016) · Springer eBooks · doi:10.1007/978-3-319-41761-5_13 · Cited by 1
Androgen Receptor-Targeted Therapy for Breast Cancer
Lyons, T. G., & Traina, T. A. (2017) · Current Breast Cancer Reports · doi:10.1007/s12609-017-0261-8 · Cited by 1
Androgen receptor expression in hormone-negative breast cancers and its prognostic significance
Abouelfadl, D. M., Amin, H. A. A., Yassen, N. N., Shabana, M., & Salem, A. M. H. (2018) · Journal of The Arab Society for Medical Research · doi:10.4103/jasmr.jasmr_21_18 · Cited by 1
Expression of androgen receptor and its regulatory molecule Lin28 in non‑luminal subtype breast cancer
Sa-nguanraksa, D., Pongthong, W., Samarnthai, N., Mitpakdi, K., Chuangsuwanich, T., Limjindaporn, T., Kulprom, A., & O‐charoenrat, P. (2020) · Molecular and Clinical Oncology · doi:10.3892/mco.2020.2029 · Cited by 1
The CAG repeat polymorphism of the androgen receptor gene and breast cancer
Nowacka‐Zawisza, M., Forma, E., Urbańska, A., Romanowicz‐Makowska, H., Bryś, M., & Krajewska, W. M. (2014) · Open Life Sciences · doi:10.2478/s11535-014-0325-y
Prevalencia de receptores androgénicos en el cáncer de mama
Rodríguez-Silva, C., González-Vela, J. L., & Velázquez-Pacheco, A. A. (2015) · Gaceta Mexicana de Oncología · doi:10.1016/j.gamo.2015.05.001
Role(s) of androgens in breast cancer biology and treatment
Sasano, H., McNamara, K. M., & Yoda, T. (2013) · Breast Cancer Management · doi:10.2217/bmt.13.2
aaaaaaaaa. Progesterone and Overlooked Endocrine Pathways in Breast Cancer Pathogenesis
Brisken, C., Hess, K. P., & Jeitziner, R. (2015)
Novel twists in hormone-mediated carcinogenesis
Tilley, W. D. (2016) · Endocrine Related Cancer · doi:10.1530/erc-16-0466
Mammary Gland-Endocrinology
Furth, P. A., Afridi, S., Alothman, S. J., Azhar, R. I., Gusain, L. Y., Shreeves, S. M., Wang, W., & Zomorrodi, D. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-801238-3.64698-6
Prevalence of androgen receptor positivity in triple negative breast cancers: clinico-pathological significance
Das, D. D. (2019) · Journal of Medical Science And clinical Research · doi:10.18535/jmscr/v7i1.142
The Breast
Barbieri, R. L. (2013) · Elsevier eBooks · doi:10.1016/b978-1-4557-2758-2.00011-1
Resumen de tesis. Identificación de determinantes genéticos y molecurales asociados a los mirnas en la variabilidad de la evolución y respuesta al tratamiento del cáncer de mama
Galvis-Jiménez, J. M. (2020) · doi:10.14201/gredos.145512
Androgen Receptors in the Pathology of Disease
Leung, J. K., Tien, A. H., & Sadar, M. D. (2021) · Springer eBooks · doi:10.1007/978-3-030-78315-0_16
Androgen Receptor Expression Associates With Distinctive Clinicopathological and Molecular Features in ER-Positive and ER-Negative Breast CancerPreprint
Hu, T., Liu, Y., Zhao, G., Wang, S., & Long, M. (2021) · Research Square · doi:10.21203/rs.3.rs-958949/v1
Are we ready to embrace novel therapeutic targets for women with AR-positive or AR-negative metastatic Triple-Negative Breast Cancer ?
Rygie, K. (2021) · Asia-Pacific Journal of Oncology · doi:10.32948/ajo.2021.07.28
Androgen Receptor Expression Associates With Distinctive Clinicopathological and Molecular Features in ER-Positive and ER-Negative Breast CancerPreprint
Hu, T., Liu, Y., Zhao, G., Wang, S., & Long, M. (2021) · Research Square · doi:10.21203/rs.3.rs-958949/v2
Androgens
Rao, P. S. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-386454-3.00237-2
Secreted Indicators of Androgen Receptor Activity in Breast Cancer Pre-Clinical Models.Preprint
Hanamura, T., Christenson, J. L., O’Neill, K. I., Rosas, E., Spoelstra, N. S., Williams, M. M., & Richer, J. K. (2021) · Research Square · doi:10.21203/rs.3.rs-786707/v1
Androgen receptor expression associates with distinctive clinicopathological and molecular features in ER-positive and ER-negative breast cancerPreprint
Hu, T., Liu, Y., Zhao, G., Wang, S., & Long, M. (2022) · Research Square · doi:10.21203/rs.3.rs-958949/v3
Progestinas y cáncer de mama en terapia de reemplazo hormonal: cómo actúan y qué alternativas son más seguras
Bazán-Steffens, C., & González, Ó. C. (2023) · Revista chilena de obstetricia y ginecología · doi:10.24875/rechog.22000059
Mammary Gland-Endocrinology
Furth, P. A. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-21477-6.00081-x
Androgen Receptor Influenced Recurrence Score Correlation in Hormone Positive and HER2 Negative Breast Cancer Indian Patients: A Comparative Approach
Chowdhury, A. R., Swain, S. S., Mohanty, S. K., & Banerjee, B. (2024) · Genome Integrity · doi:10.14293/genint.15.1.001
Investigation of the effects of small VCP-interacting protein (SVIP)on the migration and invasion of breast cancer cells
Kartal, B., Alimoğulları, E., & Çaylı, S. (2025) · Pathology - Research and Practice · doi:10.1016/j.prp.2025.155929
Androgen Receptor Positivity in Non-Metastatic Breast Cancer Patients and Its Prognostic Implications—A Retrospective Study
Bhargavan, R. V., Mathews, A., Subhadradevi, L., Krishna, J. K. M., Cherian, K., & Augustine, P. (2025) · Indian Journal of Surgical Oncology · doi:10.1007/s13193-025-02346-0
The predictive value of metabolomic-related biomarkers in breast cancers: Current approaches in biotechnology
Nishanthan, A. F., Jahja, E., Peshkova, T., Shaikh, N. P., Shaikh, A. P., Barua, J. D., & Nakashidze, I. (2025) · Euchembioj Reviews · doi:10.62063/rev-22
Developmental basis of male nipple loss and retention in mammalsPreprint
Zheng, Z., Wang, S., & Cooke, A. (2025) · Research Square · doi:10.21203/rs.3.rs-7697632/v1
Role of ERβ in Triple-Negative Breast Cancer Associated with p53 and Androgen Receptor
Ito, K., Honma, N., Ogata, H., Yamada, A., Miyashita, M., Arai, T., Sasaki, E., Shibuya, K., Mikami, T., & Sawaki, M. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms262311459
Additional file 5 of Secreted indicators of androgen receptor activity in breast cancer pre-clinical models
Hanamura, T., Christenson, J. L., O’Neill, K. I., Rosas, E., Spoelstra, N. S., Williams, M. M., & Richer, J. K. (2021) · Figshare · doi:10.6084/m9.figshare.16935909
Additional file 10 of Secreted indicators of androgen receptor activity in breast cancer pre-clinical models
Hanamura, T., Christenson, J. L., O’Neill, K. I., Rosas, E., Spoelstra, N. S., Williams, M. M., & Richer, J. K. (2021) · Figshare · doi:10.6084/m9.figshare.16935885
Additional file 8 of The androgen receptor interacts with GATA3 to transcriptionally regulate a luminal epithelial cell phenotype in breast cancer
Hosseinzadeh, L., Kikhtyak, Z., Laven‐Law, G., Pederson, S., Puiu, C. G., D’Santos, C. S., Lim, E., Carroll, J. S., Tilley, W. D., Dwyer, A. R., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26677058
Additional file 9 of The androgen receptor interacts with GATA3 to transcriptionally regulate a luminal epithelial cell phenotype in breast cancer
Hosseinzadeh, L., Kikhtyak, Z., Laven‐Law, G., Pederson, S., Puiu, C. G., D’Santos, C. S., Lim, E., Carroll, J. S., Tilley, W. D., Dwyer, A. R., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26677061
Additional file 1 of The androgen receptor interacts with GATA3 to transcriptionally regulate a luminal epithelial cell phenotype in breast cancer
Hosseinzadeh, L., Kikhtyak, Z., Laven‐Law, G., Pederson, S., Puiu, C. G., D’Santos, C. S., Lim, E., Carroll, J. S., Tilley, W. D., Dwyer, A. R., et al. (2024) · Figshare · doi:10.6084/m9.figshare.25150638
Additional file 2 of The androgen receptor interacts with GATA3 to transcriptionally regulate a luminal epithelial cell phenotype in breast cancer
Hosseinzadeh, L., Kikhtyak, Z., Laven‐Law, G., Pederson, S., Puiu, C. G., D’Santos, C. S., Lim, E., Carroll, J. S., Tilley, W. D., Dwyer, A. R., et al. (2024) · Figshare · doi:10.6084/m9.figshare.25150694
Additional file 11 of Secreted indicators of androgen receptor activity in breast cancer pre-clinical models
Hanamura, T., Christenson, J. L., O’Neill, K. I., Rosas, E., Spoelstra, N. S., Williams, M. M., & Richer, J. K. (2021) · Figshare · doi:10.6084/m9.figshare.16935888
Additional file 1 of Secreted indicators of androgen receptor activity in breast cancer pre-clinical models
Hanamura, T., Christenson, J. L., O’Neill, K. I., Rosas, E., Spoelstra, N. S., Williams, M. M., & Richer, J. K. (2021) · Figshare · doi:10.6084/m9.figshare.16935897
Additional file 5 of The androgen receptor interacts with GATA3 to transcriptionally regulate a luminal epithelial cell phenotype in breast cancer
Hosseinzadeh, L., Kikhtyak, Z., Laven‐Law, G., Pederson, S., Puiu, C. G., D’Santos, C. S., Lim, E., Carroll, J. S., Tilley, W. D., Dwyer, A. R., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26677049
Additional file 9 of Secreted indicators of androgen receptor activity in breast cancer pre-clinical models
Hanamura, T., Christenson, J. L., O’Neill, K. I., Rosas, E., Spoelstra, N. S., Williams, M. M., & Richer, J. K. (2021) · Figshare · doi:10.6084/m9.figshare.16935921
Additional file 6 of The androgen receptor interacts with GATA3 to transcriptionally regulate a luminal epithelial cell phenotype in breast cancer
Hosseinzadeh, L., Kikhtyak, Z., Laven‐Law, G., Pederson, S., Puiu, C. G., D’Santos, C. S., Lim, E., Carroll, J. S., Tilley, W. D., Dwyer, A. R., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26677052
Additional file 3 of The androgen receptor interacts with GATA3 to transcriptionally regulate a luminal epithelial cell phenotype in breast cancer
Hosseinzadeh, L., Kikhtyak, Z., Laven‐Law, G., Pederson, S., Puiu, C. G., D’Santos, C. S., Lim, E., Carroll, J. S., Tilley, W. D., Dwyer, A. R., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26677043
Additional file 3 of Secreted indicators of androgen receptor activity in breast cancer pre-clinical models
Hanamura, T., Christenson, J. L., O’Neill, K. I., Rosas, E., Spoelstra, N. S., Williams, M. M., & Richer, J. K. (2021) · Figshare · doi:10.6084/m9.figshare.16935903
Additional file 7 of Secreted indicators of androgen receptor activity in breast cancer pre-clinical models
Hanamura, T., Christenson, J. L., O’Neill, K. I., Rosas, E., Spoelstra, N. S., Williams, M. M., & Richer, J. K. (2021) · Figshare · doi:10.6084/m9.figshare.16935915
Additional file 6 of Secreted indicators of androgen receptor activity in breast cancer pre-clinical models
Hanamura, T., Christenson, J. L., O’Neill, K. I., Rosas, E., Spoelstra, N. S., Williams, M. M., & Richer, J. K. (2021) · Figshare · doi:10.6084/m9.figshare.16935912
Additional file 4 of Secreted indicators of androgen receptor activity in breast cancer pre-clinical models
Hanamura, T., Christenson, J. L., O’Neill, K. I., Rosas, E., Spoelstra, N. S., Williams, M. M., & Richer, J. K. (2021) · Figshare · doi:10.6084/m9.figshare.16935906
Additional file 2 of Secreted indicators of androgen receptor activity in breast cancer pre-clinical models
Hanamura, T., Christenson, J. L., O’Neill, K. I., Rosas, E., Spoelstra, N. S., Williams, M. M., & Richer, J. K. (2021) · Figshare · doi:10.6084/m9.figshare.16935900
Additional file 7 of The androgen receptor interacts with GATA3 to transcriptionally regulate a luminal epithelial cell phenotype in breast cancer
Hosseinzadeh, L., Kikhtyak, Z., Laven‐Law, G., Pederson, S., Puiu, C. G., D’Santos, C. S., Lim, E., Carroll, J. S., Tilley, W. D., Dwyer, A. R., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26677055
Additional file 13 of Secreted indicators of androgen receptor activity in breast cancer pre-clinical models
Hanamura, T., Christenson, J. L., O’Neill, K. I., Rosas, E., Spoelstra, N. S., Williams, M. M., & Richer, J. K. (2021) · Figshare · doi:10.6084/m9.figshare.16935894
Additional file 11 of The androgen receptor interacts with GATA3 to transcriptionally regulate a luminal epithelial cell phenotype in breast cancer
Hosseinzadeh, L., Kikhtyak, Z., Laven‐Law, G., Pederson, S., Puiu, C. G., D’Santos, C. S., Lim, E., Carroll, J. S., Tilley, W. D., Dwyer, A. R., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26677067
Additional file 4 of The androgen receptor interacts with GATA3 to transcriptionally regulate a luminal epithelial cell phenotype in breast cancer
Hosseinzadeh, L., Kikhtyak, Z., Laven‐Law, G., Pederson, S., Puiu, C. G., D’Santos, C. S., Lim, E., Carroll, J. S., Tilley, W. D., Dwyer, A. R., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26677046
Additional file 12 of Secreted indicators of androgen receptor activity in breast cancer pre-clinical models
Hanamura, T., Christenson, J. L., O’Neill, K. I., Rosas, E., Spoelstra, N. S., Williams, M. M., & Richer, J. K. (2021) · Figshare · doi:10.6084/m9.figshare.16935891
Additional file 8 of Secreted indicators of androgen receptor activity in breast cancer pre-clinical models
Hanamura, T., Christenson, J. L., O’Neill, K. I., Rosas, E., Spoelstra, N. S., Williams, M. M., & Richer, J. K. (2021) · Figshare · doi:10.6084/m9.figshare.16935918
Additional file 10 of The androgen receptor interacts with GATA3 to transcriptionally regulate a luminal epithelial cell phenotype in breast cancer
Hosseinzadeh, L., Kikhtyak, Z., Laven‐Law, G., Pederson, S., Puiu, C. G., D’Santos, C. S., Lim, E., Carroll, J. S., Tilley, W. D., Dwyer, A. R., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26677064
In silico disruption of TGF-β signalling in AR-deficient triple-negative breast cancer via AMP-based therapeutics
Chakraborty, A., Taj, Z., Raashika, K., Singh, L. C., & Chattopadhyay, I. (2025) · In Silico Research in Biomedicine · doi:10.1016/j.insi.2025.100163
Single cell RNA-sequencing reveals an association between testosterone treatment and reduced hormone signaling in the human mammary glandPreprint
Phong, K. T., Song, S., Kim, E. A., Conrad, D., & Gartner, Z. J. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2025.12.31.697241
Contribution à l’étude des mécanismes de sensibilité aux traitements antiandrogènes dans les cancers du sein moléculaires apocrines
Grellety, T. (2018) · doi:10.70675/c8ba4d07z1e7bz4f3az969cz7ae3bff65946
Late gestational exposure to flutamide alters stromal composition and immune landscape in the rat mammary gland during pre-puberty, peri-puberty, and adulthood
Tovar‐Parra, D., McDermott, A., Cardot, J., Juarez, M., Joao, F., Omri-Charai, R. E., Berthiaume, L., Dhawan, B., Aghigh, A., Breton, Y., et al. (2026) · Toxicological Sciences · doi:10.1093/toxsci/kfag053
“AR”e We Ignoring the Role of Androgen Receptor (AR) in Breast Carcinomas?
Jaine, N. S., Elhence, P. A., Vedant, D., Vishwajeet, V., Aggarwal, D., Chaudhary, R. K., Pareek, P., & Vishnoi, J. R. (2026) · International Journal of Surgical Pathology · doi:10.1177/10668969261449834
Androgen-regulated miRNA-mRNA interactions in luminal A breast cancer: Insights into metastasis, anoikis resistance, and metabolic pathwaysPreprint
Yasin, J. A., Alkuttob, L. A., Adwan, S., Abdulla, M., Mansour, A., Alsafadi, D. B., Odat, R., & Ahram, M. (2026) · Research Square · doi:10.21203/rs.3.rs-9954513/v1
Nucleic sexual hormone receptor signaling pathways in breast cancer: function regulation, crosstalk, and therapeutic implications
Zeng, K., Wang, A., Sun, H., Wang, C., Wang, C., Zou, R., Yang, D., Bai, Y., Wang, M., Xu, Y. Y., et al. (2026) · npj Precision Oncology · doi:10.1038/s41698-026-01568-x
Beyond the canonical view: steroid receptor network plasticity and mechanosensitive chromatin integration in breast cancer
García-García, J., Pérez, R. S., Nacht, A. S., Presman, D. M., Pecci, A., & Vicent, G. P. (2026) · NAR Cancer · doi:10.1093/narcan/zcag016
Hormone Therapy Considerations for Breast Cancer Survivors and High-Risk Women
Sanserino, K. A. (2026) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2026.07.002
BindingDB Entry 50047331: 7-Substituted umbelliferone derivatives as androgen receptor antagonists for the potential treatment of prostate and breast cancer.
BindingDB (2017) · UC San Diego · doi:10.7270/q2mk6fs1
BindingDB Entry 50016515: Nucleic-Acid-Based Targeted Degradation in Drug Discovery.
BindingDB (2023) · UC San Diego · doi:10.7270/q2k35zpc

Authors: Hickey, T. E., Robinson, J. L. L., Carroll, J. S., & Tilley, W. D.
Affiliations: Hanson Institute (AU)
University of Cambridge (GB)
Corresponding author: Tilley, W. D.
ORCID: Hickey, T. E.
Robinson, J. L. L.
Carroll, J. S.
Tilley, W. D.
Venue: Molecular Endocrinology
Publisher: The Endocrine Society
Published: 2012-08-01
Volume: 26
Issue: 8
Pages: 1252-1267
ISSN: 0888-8809 (ISSN-L)
1944-9917
DOI: 10.1210/me.2012-1107
PMC: PMC3404296
OpenAlex: W1974738527
Cited by: 289
References: 152
Citations by year: 2026: 10 · 2025: 12 · 2024: 15 · 2023: 11 · 2022: 15 · 2021: 40 · 2020: 16 · 2019: 19 · 2018: 27 · 2017: 18 · 2016: 29 · 2015: 22 · 2014: 30 · 2013: 24 · 2012: 1
FWCI: 3.06
Type: journal article
Language: en
Open access: bronze
doi.org
Locations: Molecular Endocrinology (publishedVersion)
Europe PMC (PubMed Central) (publishedVersion)
PubMed Central (publishedVersion)
PubMed (publishedVersion)
Adelaide Research & Scholarship (AR&S) (University of Adelaide) (submittedVersion)
Funders: U.S. Department of Defense (W81XWH-11-1-, W81XWH)
European Molecular Biology Organization
Cancer Research UK
University of Cambridge
National Breast Cancer Foundation
Medical Research Council
National Health and Medical Research Council (1008349)
Topics: Life Sciences › Biochemistry, Genetics and Molecular Biology › Endocrinology › Estrogen and related hormone effects
Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Prostate Cancer Treatment and Research
Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Breast Cancer Treatment Studies
Keywords: androgen receptor, breast cancer, estrogen receptor alpha, luminal breast cancer, apocrine breast cancer, tumor suppressor, oncogenes, androgen signaling, transcriptional programs, therapeutic targeting
MeSH terms: Androgens, Animals, Breast Neoplasms, Female, Growth Inhibitors, Humans, Oncogenes, Receptors, Androgen, Signal Transduction, Genes, Tumor Suppressor, Mammary Glands, Human, Estrogen Receptor alpha

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Minireview: The Androgen Receptor in Breast Tissues: Growth Inhibitor, Tumor Suppressor, Oncogene?

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks